Showing results (631-640 of 777) with videos related to

Sort By:
Pageof 78
Urologic Oncology|September 18, 2023
Baseline prostate health index risk category and risk category changes during active surveillance predict grade reclassificationClaire M de la Calle, Yuezhou Jing, Mufaddal M Mamawala, et al.
The American Journal of Surgical Pathology|August 25, 2022
Prostate Cancer in Male-to-Female Transgender Individuals: Histopathologic Findings and Association With Gender-affirming Hormonal TherapyEzra Baraban, Chien-Kuang C Ding, Marissa White, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 20, 2005
Stronger association between obesity and biochemical progression after radical prostatectomy among men treated in the last 10 yearsStephen J Freedland, William B Isaacs, Leslie A Mangold, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 23, 2025
Extragonadal Urinary Tract Neoplasms With Yolk Sac Differentiation: Clinical, Histologic, and Molecular Evidence of Derivation From Underlying Urothelial CarcinomaLéonie Beauchamp, Roy Elias, Adam D Toll, et al.
European Urology|June 28, 2014
The relationship between the extent of extraprostatic extension and survival following radical prostatectomyByong Chang Jeong, Heather J Chalfin, Seung Bae Lee, et al.
European Urology|May 24, 2021
External Validation and Addition of Prostate-specific Membrane Antigen Positron Emission Tomography to the Most Frequently Used Nomograms for the Prediction of Pelvic Lymph-node Metastases: an International Multicenter StudyDennie Meijer, Pim J van Leeuwen, Matthew J Roberts, et al.
Histopathology|March 9, 2025
Interobserver reproducibility of a hybrid three-tier grading system of papillary nonmuscle invasive urothelial carcinoma: an international Uropathology studyMichelle R Downes, Katherine Lajkosz, Ferran Algaba, et al.
BJU International|September 30, 2010
Prediction of patient-specific risk and percentile cohort risk of pathological stage outcome using continuous prostate-specific antigen measurement, clinical stage and biopsy Gleason scoreYing Huang, Sumit Isharwal, Alexander Haese, et al.
Clinical Genitourinary Cancer|May 25, 2015
Multimodal Therapy in the Treatment of Prostate Sarcoma: The Johns Hopkins ExperienceMark W Ball, Debasish Sundi, Adam C Reese, et al.
The Journal of Urology|December 18, 2023
Risk of Biochemical Recurrence in Patients With Grade Group 1 Prostate Cancer With Extraprostatic Extension Treated With Radical ProstatectomyMichael E Rezaee, Maximilian Pallauf, Sean A Fletcher, et al.
Pageof 78